Trial
NCT03333486
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Roswell Park Cancer Institute
Collaborators
—
Condition
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Intervention
Cyclophosphamide
Why stopped
Futility analysis determined closure
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-04